The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
wyeth | 6658 |
janssen alzheimer immunotherapy | 204 |
wyeth holdings corporation | 170 |
zoetis w | 103 |
elan pharma international | 77 |
zoetis services | 76 |
medimmune | 74 |
nestec | 69 |
elan pharmaceuticals | 43 |
progenics pharmaceuticals | 39 |
wyeth | 190 |
zoetis services | 13 |
wyeth holdings corporation | 6 |
nestec | 5 |
ablynx | 4 |
pfizer italia | 4 |
aptevo research and development | 3 |
progenics pharmaceuticals | 2 |
zoetis w | 1 |
ziarco | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
novel immunogenic compositions for the prevention and treatment of meningococcal disease | 127 | 2001 |
triazine compounds as p13 kinase and mtor inhibitors | 80 | 2008 |
circovirus sequences associated with piglet weight loss disease (pwd) | 77 | 1997 |
multivalent pneumococcal polysaccharide-protein conjugate composition | 76 | 2005 |
maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-qu… 🛈 | 73 | 2007 |
prevention and treatment of amyloidogenic disease | 64 | 1997 |
novel formulations which stabilize and inhibit precipitation of immunogenic compositions | 59 | 2006 |
compositions relating to a mutant clostridium difficile toxin and methods thereof | 58 | 2011 |
oral formulations and lipophilic salts of methylnaltrexone | 57 | 2010 |
designer osteogenic proteins | 56 | 2010 |